Last reviewed · How we verify
NCT04214873
Evaluation of the Effectiveness of the PiQo4 System for Reduction of Infra-orbital Pigmentation
NA trial testing PiQo4 Laser System in POH in 8 participants. Completed in 20 January 2022.
20 January 2022
Quick facts
| Lead sponsor | Focus Medical, LLC |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 8 |
| Start date | 6 January 2020 |
| Primary completion | 20 January 2022 |
| Estimated completion | 20 January 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- PiQo4 Laser System
Conditions studied
- POH — all drugs for POH →
Sponsor
Focus Medical, LLC
Who can join
Adults 18 to 65, any sex, with POH. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A total of 10 healthy subjects at a single site, aged 18-65 years old and Fitzpatrick skin type I-IV with mild to moderate infra-orbital hyperpigmentation on the background of epidermal and/or dermal pigmentation that wish to improve their POH
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04214873
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of PiQo4 Laser System
Trials testing the same drug.
- NCT03565146 — Evaluation of the Efficacy and Safety of PiQo4 System for the Treatment of Pigmented Lesions · NA · completed
Other Focus Medical, LLC trials
Trials by the same sponsor.
- NCT03565341 — Efficacy and Safety of PiQo4 Device for Treatment of Melasma · NA · completed
- NCT03565146 — Evaluation of the Efficacy and Safety of PiQo4 System for the Treatment of Pigmented Lesions · NA · completed
- NCT03322475 — Evaluation of the Efficacy and Safety of PiQo4 for Facial Skin Rejuvenation · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04214873 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Focus Medical, LLC
- Last refreshed: 3 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04214873.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing